Multiple cerebral gliomas mimicking central nervous system inflammatory demyelinating diseases: A rare case with review of literature. Issue 52 (December 2017)

• Record Type: Journal Article
• Authors: Xiong, Yong-Jie; Zhao, Xin-ling; Wang, Xiao-Yan; Pan, Deng-Ji; Tian, Dai-Shi
• Other Names: Wu. Wanqing section editor.
• Is Part Of: Medicine. Volume 96:Issue 52(2017)
• Publication Date: 2017-12
• Subjects: astrocytoma -- brain neoplasms -- demyelinating diseases -- diagnosis -- differential; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000009456
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Rationale: Multiple cerebral gliomas (MCGs), usually classified into multifocal and multicentric subtypes, represent major diagnostic challenges as their clinical, radiologic, and pathohistological features are not uniform, often mimicking brain metastatic tumors or central nervous system inflammatory demyelinating diseases (IDD). Patient concerns: Here, we report a rare case of MCGs with isolated seizures and 4 lesions in the brain, that was initially misdiagnosed as IDD during treatment. Diagnosis: The pathological diagnosis was astrocytoma, which was classified as a World Health Organization grade II glioma. Interventions: The patient was treated with dexamethasone and sodium valproate when he was misdiagnosed as having IDD. After the pathological diagnosis was obtained, he was treated with temozolomide and radiotherapy. Outcomes: Three months after the above treatment, the health of the patient had improved; he was asymptomatic, and presented with better radiological manifestations. Lessons: Diagnostic imaging is valuable in differential diagnosis. Magnetic resonance spectroscopy is a promising technique for the assessment and characterization of lesions, though its role in definitive diagnosis is not yet defined. Brain tissue biopsy remains the golden standard for definitive diagnosis. In China, for various reasons, craniotomy biopsy is not performed routinely in patients with multiple intracranial lesions, and stereotactic cranial biopsy may be a more viable option because of its safety and cost-effectiveness. In summary, this case demonstrates that MCGs need to be included in the differential diagnosis of unknown intracranial multiple lesions. Abstract : Supplemental Digital Content is available in the text